H2Ocean courts cancer researchers with sea-salt oral care pitch

H2Ocean used CPRIT Innovations VII in Galveston to promote sea-salt-based oral care as a possible supportive option for cancer patients and survivors. The company met with researchers, clinicians and CPRIT leaders as the conference spotlighted survivorship, quality of life and new prevention efforts.

Why it matters: - H2Ocean is trying to position natural sea-salt oral care as a supportive option for people dealing with cancer treatment side effects. - The company framed oral comfort, hygiene and quality of life as an unmet need during chemotherapy, radiation and recovery. - The conference drew more than 600 attendees, giving H2Ocean direct access to cancer researchers, clinicians and industry leaders.

What happened: - H2Ocean participated in CPRIT Innovations VII, held Oct. 5-7, 2026, at the Moody Gardens Hotel, Spa & Convention Center in Galveston, Texas. - The company sent Founder and CEO Eddie Kolos and Chief Scientific Officer Dr. Rajiv Saini to the conference. - H2Ocean used its exhibition booth to discuss sea-salt-based formulations, supportive oral care and product samples with attendees. - CPRIT organized the event, which included about 60 speakers and more than 250 scientific poster presentations. - Kristen Doyle, CPRIT CEO, and Heidi McConnell, CPRIT deputy executive officer and COO, visited the H2Ocean booth and spoke with the company’s leaders.

The details: - H2Ocean said attendees showed interest in how mineral-rich sea-salt formulations could support oral comfort, oral hygiene and quality of life for patients undergoing or recovering from cancer treatment. - The company said cancer therapies can contribute to oral mucositis, dry mouth, oral discomfort and difficulty maintaining routine oral hygiene. - H2Ocean said these complications can affect nutrition, comfort and overall quality of life. - The company’s sea-salt oral care formulations are designed for gentle cleansing and oral hygiene. - H2Ocean said further clinical research is needed to establish benefits in oncology populations. - The company said its products are meant to complement, not replace, cancer prevention strategies, oncology treatment or professional medical guidance. - H2Ocean said the conference also created opportunities for potential collaborative research, clinical evaluation and educational initiatives. - The company said it has been building on its 2024 CPRIT conference participation. - H2Ocean also said it is a healthcare product innovation company focused on natural sea-salt formulations for oral care, skin care, hair care, first aid and aftercare. - The company’s booth also distributed educational information about its products. - A key theme of the conference was survivorship and long-term outcomes alongside treatment advances. - Discussions at CPRIT Innovations VII covered emerging therapies, early detection, screening, translational research, biotech commercialization, clinical trials and access to preventive services. - The conference also highlighted artificial intelligence in science, lab-to-clinic translation, community-based prevention and research partnerships. - CPRIT unveiled the Texas Cervical Cancer Elimination Plan 2027-2032 during the event. - The plan is intended to accelerate progress through prevention, screening and coordinated healthcare efforts. - The Texans Conquer Cancer Awards opened the conference with recognition for research, prevention, innovation and clinical care. - CPRIT honored Dr. Zhiqiang An of UTHealth Houston for Innovation, Dr. Keith Argenbright of UT Southwestern Medical Center for Population Health, Dr. Abbey Berenson of the University of Texas Medical Branch for Clinical Care and Dr. Michael D. Taylor of Baylor College of Medicine for High Impact Research. - CPRIT also gave Champion Awards to Annette Leslie, founder of the Carson Leslie Foundation, and Wayne Roberts, former CEO of CPRIT.

Between the lines: - H2Ocean is using the cancer conference circuit to link a consumer health product category with supportive oncology care. - The company’s messaging suggests it sees a pathway to research collaboration before any broader clinical validation. - The focus on survivorship and quality of life fits a broader shift in cancer care toward managing day-to-day treatment burdens, not just treating disease.

What's next: - H2Ocean said it plans to build on the relationships formed at CPRIT Innovations VII. - The company wants to pursue future discussions about supportive healthcare innovation, oral health and quality of life for cancer patients and survivors. - H2Ocean said it remains interested in scientific evaluation of sea-salt-based formulations in oncology settings. - The company also said it hopes to continue exploring collaborative research and patient-centered supportive care applications.

The bottom line: - H2Ocean is betting that natural sea-salt oral care can earn a place in the conversation around cancer survivorship, but the company acknowledges that more research is needed before those claims can be established.